MPT
Spain
MPT
Spain

Time filter

Source Type

BUFFALO, NY--(Marketwired - May 15, 2017) - Cleveland BioLabs, Inc. ( : CBLI) today reported financial results and development progress for the first quarter ended March 31, 2017. Cleveland BioLabs reported a net loss of $(1.7) million, excluding minority interests, for the first quarter of 2017, or $(0.15) per share, compared to a net loss, excluding minority interests, of $(0.7) million, or $(0.06) per share, for the same period in 2016. The increase in net loss was primarily due to an increase in the non-cash adjustment to our warrant liabilities and decreased revenues and expenses due to the completion of our development contracts with the Russian Federation Ministry of Industry and Trade ("MPT"), which was partially offset by reduced operating costs aligned with our streamlined focus primarily on pursuing a pre Emergency Use Authorization ("pre-EUA") with the U.S. Food and Drug Administration ("FDA") and a Marketing Authorization Application ("MAA") with the European Medicines Agency ("EMA") for entolimod as a medical radiation countermeasure. As of March 31, 2017, the Company had $13.1 million in cash, cash equivalents and short-term investments, which, based on the Company's current operational plan, is estimated to fund operations for at least one year beyond the filing date of our Form 10-Q. Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, "The pursuit of commercialization for entolimod as a medical radiation countermeasure remains our top priority. As previously announced, we are excited to have received agreement from the FDA to commence the in vivo biocomparability study in non-human primates. Following completion of this study and discussion of the study results with the FDA, we expect the agency to resume the review of our pre-EUA dossier." "We are also excited to have received a positive opinion from EMA on our pediatric investigational plan and are diligently working on assembling our MAA for submission to EMA," added Dr. Kogan. Revenue for the first quarter of 2017 decreased to $0.6 million compared to $0.8 million for the first quarter of 2016. The net decrease was primarily attributable to reduced revenue from our development contracts with MPT which completed in 2016. This decrease was partially offset by increased revenue from our Joint Warfighter Medical Research Program ("JWMRP") contract from the Department of Defense ("DoD") for the continued development of the entolimod as a medical radiation countermeasure. Research and development costs for the first quarter of 2017 decreased to $1.4 million compared to $1.9 million for the first quarter of 2016. The reduction in research and development costs is due to completion of our development contract with MPT and was offset, in part, by continued preclinical development along with other drug manufacturing activities associated with our JWMRP contract. General and administrative costs for the first quarter of 2017 decreased to $0.8 million compared to $1.2 million for the first quarter of 2016. This decrease was primarily attributable to reductions in personnel and other operating costs in connection with cost savings efforts to streamline operations. About Cleveland BioLabs, Inc. Cleveland BioLabs, Inc. is an innovative biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. The company's proprietary platform of Toll-like immune receptor activators has applications in radiation mitigation, immuno-oncology, and vaccines. The company's most advanced product candidate is entolimod, which is being developed as a medical radiation countermeasure for the prevention of death from acute radiation syndrome, an immunotherapy for oncology and other indications. The company conducts business in the United States and in the Russian Federation through a wholly-owned subsidiary, BioLab 612, LLC, and a joint venture with Joint Stock Company RUSNANO, Panacela Labs, Inc. The company maintains strategic relationships with the Cleveland Clinic and Roswell Park Cancer Institute. To learn more about Cleveland BioLabs, Inc., please visit the company's website at http://www.cbiolabs.com. This press release contains certain forward-looking information about Cleveland BioLabs that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that do not relate strictly to historical or current facts. Words and phrases such as "potential," "may," "future," "will," "plan," "anticipate," "believe," "intend," "expect" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the company's future financial position, business strategy, new products, budgets, liquidity, cash flows, projected costs, research and clinical analyses and trials, regulatory approvals or the impact of any laws or regulations applicable to the company, and plans and objectives of management for future operations. All of such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of the company, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Factors that could contribute to such differences include, among others, the risks inherent in the early stages of drug development and in conducting clinical trials; the company's plans and expectations with respect to future clinical trials and commercial scale-up activities; the company's ability to attract collaborators with development, regulatory and commercialization expertise and the financial risks related to those relationships; the company's ability to comply with its obligations under license agreements; the company's inability to obtain regulatory approval in a timely manner or at all; the commercialization of the company's product candidates, if approved; the company's plans to research, develop and commercialize its product candidates; future agreements with third parties in connection with the commercialization of any approved product; the size and growth potential of the markets for the company's product candidates, and its ability to serve those markets; the rate and degree of market acceptance of the company's product candidates; the company's history of operating losses and the potential for future losses, which may lead the company to not be able to continue as a going concern; regulatory developments in the United States and foreign countries; the performance of the company's third-party suppliers and manufacturers; and the success of competing therapies that are or may become available. Some of these factors could cause future results to materially differ from the recent results or those projected in forward-looking statements. Any forward-looking statements speak only as of the date on which such statements are made, and the company undertakes no obligation to update any forward-looking statement to reflect events or circumstances occurring or arising after the date on which such statement is made, except as may be required by law. See also the "Risk Factors" and "Forward-Looking Statements" described in the company's periodic filings with the Securities and Exchange Commission.


BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that it has signed definitive agreements to acquire the real estate interests of ten acute care hospitals and one behavioral health facility currently operated by IASIS Healthcare (“IASIS”) and to be operated by Steward Health Care System LLC (“Steward”) when the transaction is completed. The $1.4 billion real estate transaction will be immediately accretive to normalized FFO per share by approximately $0.10 (and to net income by $0.05 per share) in 2018 assuming all debt financing. Steward and IASIS separately announced a simultaneous merger transaction, completion of which is a condition of MPT’s investment. “ We are very excited about this opportunity to grow with one of the top hospital operators in the country,” said Edward K. Aldag, Jr., MPT’s Chairman, President and Chief Executive Officer. “ MPT has grown its assets by approximately 31 percent annually since 2013, compared to 15 percent for our healthcare REIT peers, and with this transaction, we eclipse our previous record 2016 acquisition total. This phenomenal growth, even as we sold almost $800 million of assets in the first half of 2016 to reduce leverage, has resulted in our normalized FFO per share growing over 10% annually compared to 6.7% for our peers for the period. Our dividend growth of 4% annually has also outperformed while our dividend payout ratio declined from 83% to 70% of normalized FFO. “ Steward has similarly achieved remarkable success in growing its company starting with the turnaround of a struggling not-for-profit hospital system in eastern Massachusetts. As Steward implemented its strategic plan to develop an integrated network with various access points along the healthcare continuum, the results were improved outcomes and reduced costs. The combined capabilities of Steward and IASIS will create the largest private for-profit hospital operator in the United States with projected revenues of almost $8 billion in 2018, the first full year of consolidated operations. Consolidation will continue in this dynamic healthcare environment and Steward is in a good position to capitalize on this trend,” added Aldag. MPT’s interests in the hospitals to be acquired will be subject to a master lease and mortgage loan arrangements with cross default provisions and backed by a corporate guaranty. Nine hospitals will be purchased for $700 million and leased back to Steward under the master lease, which has an expiration date of October 31, 2031, and includes three five-year extension terms, resulting in a GAAP yield of 10.2%. The new mortgage loans, also aggregating $700 million, have the same contractual terms as the leases. Additionally, MPT is making an attractive $100 million preferred equity investment in Steward, which will provide low risk equity-like returns. MPT’s pro forma investment of $3.3 billion in Steward real estate will include MPT’s existing investment in hospital real estate leased to IASIS, and generate approximately $298 million in annual revenue split 67% rental income and 33% interest income from mortgages. Expected 2018 EBITDAR rent and interest coverage for all Steward hospitals is 2.8 times. The transaction is expected to close by September 30, 2017, subject to customary approvals and consents. MPT expects to finance the acquisitions with proceeds from a combination of a fully committed $1.0 billion term loan with a term up to two years, its revolving credit facility with present availability of approximately $1.0 billion and the possible issuance of long-term unsecured notes. The Company intends to maintain its prudent leverage position and does not expect net debt to adjusted EBITDA to exceed 5.7 times. The Company has posted a presentation regarding the Steward transaction, including a reconciliation of pro forma FFO per diluted share to Net Income, the most comparable GAAP measure, on the Investor Relations page of the Company’s website, www.medicalpropertiestrust.com under Webcasts & Presentations. Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. For more information, please visit the Company’s website at www.medicalpropertiestrust.com. The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: our ability to successfully consummate the Steward/IASIS transactions discussed in this press release; the satisfaction of all conditions to, and the timely closing (if at all) of pending transactions; net income per share; Normalized FFO per share; the amount of acquisitions of healthcare real estate, if any; results from the potential sales, if any, of assets; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.


News Article | May 4, 2017
Site: www.businesswire.com

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the first quarter ended March 31, 2017 through today. In addition to its outstanding results of operations and investment activities, the Company described its outlook for near-term accretive acquisitions. “With our successful equity offering last week, we are positioned to substantially increase our acquisition activity beyond our prior guidance of $1.0 billion in 2017,” said Edward K. Aldag, Jr., MPT’s Chairman, President and Chief Executive Officer. “We have already closed and committed to close on almost $450 million of our initial 2017 estimates in very high quality hospital assets, and our sector-leading balance sheet strength gives us capacity to add as much as another $1.5 billion while maintaining our very low leverage target of 5.5 times net debt to EBITDA.” “The recently announced Adeptus resolution was exactly as we expected,” said Aldag. “The commitment by affiliates of Deerfield Management to recapitalize Adeptus and assume MPT leases underscores our underwriting and the power of our master lease structure. Over the course of our 14-year history, MPT’s assets have grown to over $7 billion and the Company has never experienced a material real estate impairment. During long-term investments, tenant issues will occasionally arise, but MPT has demonstrated its ability to resolve such issues while continuously collecting its rent. The strength of our underwriting and asset management are strong protectors of our shareholders’ investments.” Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income and reconciliations of net income to FFO and Adjusted Funds from Operations (“AFFO”), all on a basis comparable to 2016 results. The Company has pro forma total gross assets of approximately $7.4 billion including $5.0 billion in general acute care hospitals, $1.8 billion in inpatient rehabilitation hospitals, and $0.4 billion in long-term acute care hospitals. The portfolio includes 258 properties representing more than 29,000 licensed beds in 29 states and in Germany, the United Kingdom, Italy and Spain. The properties are leased to or mortgaged by 31 hospital operating companies. Normalized FFO for the first quarter increased 27% to $105.9 million compared with $83.5 million in the first quarter of 2016. Per share Normalized FFO decreased 6% to $0.33 per diluted share in the first quarter compared with $0.35 per share in the first quarter of 2016 due to the Company’s successful deleveraging in 2016 that represented almost $800 million in asset sales and a well-received upsized equity offering of 57.5 million shares of common stock in September 2016, in conjunction with the acquisition of nine Steward hospitals. First quarter 2017 total revenues increased 16% to $156.4 million compared with $135.0 million for the first quarter of 2016. Net income for the first quarter of 2017 was $68.0 million (or $0.21 per diluted share), compared to $57.9 million (or $0.24 per diluted share) in the first quarter of 2016. Certain items in the first quarter included $13.6 million in charges related to debt refinancing activities; a $7.4 million gain on the sale of a hospital, and $3.7 million of acquisitions and other transaction costs. Aldag commented on the impact of the Company’s recent decision to even further strengthen its sector-leading balance sheet through last week’s increase in equity. “The impact of last week’s $548 million equity raise will temporarily dilute FFO for 2017 until we reset our capital structure from the current, historically low leverage of 4.5 times EBITDA to our long-term target of 5.0 to 5.5 times, and use that capital for immediately accretive acquisitions. We are hopeful that will happen in the relatively near term, but until we have more certainty concerning the size and timing of any additional acquisitions, we will not try to quantify the near-term impact on our prior guidance.” The Company has scheduled a conference call and webcast for Thursday, May 4, 2017 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter ended March 31, 2017. The dial-in numbers for the conference call are 855-365-5214 (U.S.) and 440-996-5721 (international); both numbers require passcode 10535403. The conference call will also be available via webcast in the Investor Relations’ section of the Company’s website, www.medicalpropertiestrust.com. A telephone and webcast replay of the call will be available beginning shortly after the call’s completion through May 18, 2017. Dial-in numbers for the replay are 855-859-2056 and 404-537-3406 for U.S. and International callers, respectively. The replay passcode for both U.S. and international callers is 10535403. The Company’s supplemental information package for the current period will also be available on the Company’s website under the “Investor Relations” section. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. For more information, please visit the Company’s website at www.medicalpropertiestrust.com. The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as "expects," "believes," "anticipates," "intends," "will," "should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the satisfaction of all conditions to, and the timely closing (if at all) of pending transactions; net income per share; Normalized FFO per share; the amount of acquisitions of healthcare real estate, if any; results from the potential sales, if any, of assets; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company's business plan; financing risks; the Company's ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the "Risk factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2016 and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.


News Article | February 15, 2017
Site: www.marketwired.com

CULVER CITY, CA--(Marketwired - Feb 9, 2017) - eWellness Healthcare Corporation, ( : EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. Darwin Fogt, MPT and CEO of the Company will be attending and holding outreach meetings with various clinical practice owner at the American Physical Therapy Association's Combined Sections Meeting (CSM) in San Antonio Texas February 16th though the 18th. There are over 11,000 physical therapists that attend this year's CSM conference. Please see the following link to view information on the CSM conference: http://www.apta.org/CSM/Overview/. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com. For additional information on eWellness Healthcare Corporation and its PHZIO telemedicine products please contact, Mr. Darwin Fogt, CEO Tel: 855-470-1700. About eWellness eWellness Healthcare Corporation ( : EWLL) is the first physical therapy telemedicine company to offer insurance reimbursable real-time distance monitored treatments. Our business model is to license our PHZIO ("PHZIO") platform to any physical therapy ("PT") clinic in the U.S. and or have large-scale employers use our PHZIO platform as a fully PT monitored corporate wellness program. The Company's PHZIO home physical therapy exercise platform has been designed to disrupt the $30 billion physical therapy and the $8 billion corporate wellness industries. PHZIO re-defines the way physical therapy can be delivered. PHZIO is the first real-time remote monitored 1-to-many physical therapy platform for home use. Due to the real-time patient monitoring feature, the PHZIO platform is insurance reimbursable by payers such as: Anthem Blue Cross and Blue Shield. For more information on eWellness go to: http://www.ewellnesshealth.com/ Forward-Looking Statements: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to eWellness Healthcare Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.


Als de op drie na[2] snelst groeiende mobiele markt ter wereld, heeft Myanmar in de afgelopen jaren een ongeëvenaarde groei in het aantal mobiele gebruikers doorgemaakt, van 10% in 2012 tot 63% in 2016[3], momenteel goed voor 6% van het totale aantal mobiele abonnees wereldwijd. MPT heeft in 2016 een 4G-netwerk gelanceerd[4], en streeft ernaar het gebruik van dit netwerk verder te ontwikkelen. Zij doet dit bijvoorbeeld door realtime gebruikers- en handsetgegevens te verzamelen en te analyseren via de geavanceerde statistische functie van Gemalto's Device Management. Andere geavanceerde oplossingen zoals AOTA geven MPT een concurrentievoordeel in het leveren van diensten op afstand, wat ook weer bijdraagt aan een vermindering van het aantal storingen en een verbetering van de klantervaring. "Deze extra faciliteiten betekenen een grote stap voorwaarts voor MPT. We kunnen onze abonnees nu veel beter begrijpen, gepersonaliseerde diensten voor hen ontwikkelen om aan hun veranderende wensen tegemoet te komen en meer zakelijke kansen benutten," zegt Koichi Kawase, Chief Commercial Officer van MPT-KSGM Joint Operations. "Ons voornaamste doel is onze klanten de best mogelijke diensten te leveren. Door deze samenwerking, die op beproefde technologieën en wereldwijde expertise is gefundeerd, kunnen we onze klanten in Myanmar nog meer gebruiksgemak en een hoogwaardige mobiele ervaring bieden." "Dankzij onze samenwerking met MPT zorgen wij voor meer vernieuwing, vertrouwen en groei op de mobiele markt van Myanmar, kunnen we nieuwe mogelijkheden aanboren en luiden we een nieuwe fase in op weg naar een steeds groter gemak voor de gebruiker," aldus Sashidhar Thothadri, Senior Vice President, Mobile Services & IoT voor Zuid-Azië en Japan bij Gemalto. "Met gebruik van onze digitale oplossingen behaalt MPT een belangrijk strategisch voordeel omdat ze zo een beter inzicht in het gedrag van abonnees krijgt, en ze haar abonnees tegelijkertijd een uitstekende connectiviteit kan bieden, waar zij zich maar bevinden." Gemalto (Euronext NL0000400653 GTO) is de wereldleider in digitale beveiliging met een jaaromzet in 2015 van € 3,1 miljard en met klanten in meer dan 180 landen. Wij bieden vertrouwen in een steeds meer verbonden wereld. De tekst van deze mededeling is een vertaling en mag geenszins als officieel worden beschouwd. De enige rechtsgeldige versie van de mededeling is die in de originele taal, het Engels, die dus voorrang heeft in geval van verschillen met de vertaling.


Quatrième[2] marché mobile au monde par la rapidité de sa croissance, le Myanmar a connu une  progression spectaculaire de la pénétration du mobile ces dernières années, passé de 10 % en 2012 à 63 % en 2016[3], ce qui représente actuellement 6 % des abonnés mobiles du monde entier. Après avoir lancé son réseau 4G en 2016[4], MPT s'est engagé à développer davantage l'usage de la 4G, notamment, par la collecte et l'analyse des données utilisateurs et combinés en temps réel via la fonction de statistiques avancées disponible dans Device Management. D'autres solutions sophistiquées comme AOTA confèrent à MPT un avantage concurrentiel pour offrir des services à distance, ce qui provoque la réduction des perturbations et l'amélioration de l'expérience client. « Ces fonctionnalités supplémentaires représentent un immense bond en avant pour MPT. Nous pouvons à présent véritablement comprendre nos abonnés, développer des services personnalisés correspondant à l'évolution de leurs besoins et doper nos opportunités commerciales », commente Koichi Kawase, directeur commercial des opérations conjointes de MPT-KSGM. « L'objectif principal de MPT est de fournir le plus haut niveau de service à nos clients. Par conséquent, cette collaboration, bâtie sur des technologies sectorielles ayant déjà fait leurs preuves et sur une expertise mondiale, nous permettra d'offrir plus de commodité aux clients au Myanmar et de leur proposer une expérience mobile irréprochable ». « Notre solide collaboration avec MPT apportera davantage d'innovation, de confiance et de croissance au marché mobile au Myanmar, en déverrouillant de nouvelles possibilités et en inaugurant une nouvelle ère de commodité pour les utilisateurs », déclare Sashidhar Thothadri, vice-président directeur des services mobiles et de l'IoT pour l'Asie du Sud et le Japon de Gemalto. « En tirant parti de notre suite de solutions, MPT sera en mesure de se forger un avantage stratégique dans sa connaissance du comportement des abonnés tandis que ces derniers seront amenés à vivre une expérience de connectivité nomade de première catégorie ». Gemalto (Euronext NL0000400653 GTO) est le leader mondial de la sécurité numérique, avec un chiffre d'affaires 2015 de 3,1 milliards d'euros et des clients dans plus de 180 pays. Nous apportons la confiance dans un monde de plus en plus interconnecté. Nos technologies et services permettent aux entreprises et aux gouvernements d'authentifier les identités mais également de protéger les données afin qu'elles restent en sécurité et assurent des services dans les appareils personnels, les objets connectés, le cloud et sur les réseaux. Présent dans 49 pays, Gemalto emploie plus de 14 000 personnes travaillant depuis 118 bureaux, 45 centres de personnalisation et de données et 27 pôles de Recherche et de Développement logiciel.


News Article | February 15, 2017
Site: www.prnewswire.co.uk

World Premiere of the Company's New Multi-Purpose Truck Concept / International Debut of the HMMWV/Hawkeye Howitzer System / HMMWV Chassis Upgrades and Services/Support Business Highlighted ABU DHABI, United Arab Emirates, Feb. 15, 2017 /PRNewswire/ -- AM General, the premiere Global Vehicle Solutions Provider, will showcase its innovative vehicle solutions, global reach and diversification at the International Defence Exhibition & Conference (IDEX) tradeshow held at the Abu Dhabi National Exhibition Centre, Feb. 19 - 23, 2017, Booth 01-C20 in the U.S. Pavilion. "IDEX 2017 is an excellent venue for AM General to display its diverse range of innovative products and services," said AM General Executive Vice President, International Defense, Larry Platt. "As the Company continues to expand and strengthen its partnerships in the region and around the globe, we will use this opportunity to engage current and potential customers, listen to their unique needs and offer them the most innovative, affordable mobility solutions available today to meet their demands." Multi-Purpose Truck / MPT - Making its world premiere at IDEX 2017, the Multi-Purpose Truck (MPT) is a commercial base 4x4 platform chassis truck (cab and chassis) with 8,391 kg (18,500 lb) GVW and 2,359 kg (5,200 lb) payload capacity engineered to serve the extreme-environment needs of energy, mining, industrial, and government customers around the world. The MPT is engineered and designed based on existing and test-proven AM General components, Off-the-Shelf (OTS) AM General items, Commercial Off-the-Shelf (COTS) items from other commercial vehicles and Military Commercial Off-the-Shelf (M-COTS) items. The MPT was designed to allow customers to configure payload modules based on their needs. The Cab & Chassis Base Platform is the base vehicle configuration. MPT modules can be developed by the purchasing country's engineering experts or, if needed, by AM General engineers. Modules can include several applicable configurations utilizing a 2-man cab. Other variants include the 2-man w/ Flat Bed, 2 + 6 Personnel Carrier, 4-man Base w/ Cargo box, and 9 Crew Capacity Vehicle. HMMWV/Hawkeye Howitzer System - Making its international debut at IDEX 2017, the HMMWV/Hawkeye Howitzer System incorporates advances in protection, payload, suspensions and life-cycle sustainment at an affordable price to meet the unique expeditionary requirements of global customers.  It exemplifies the steady evolution of the HMMWV based on customer feedback, battlefield experiences, and innovation. HMMWV Chassis Modernization – AM General is uniquely capable of tailoring upgrades and modernization programs that are based on the specific needs of each country.  These modernization efforts can range from country specific fleet surveys that recommend a set of services or component upgrades… through offering a complete modernization program that will bring earlier HMMWVs to a configuration on par with new vehicles.  The modernized chassis is designed for HMMWVs that will continue to be in the U.S. and international military fleets for 30-plus years. AM General's modernized chassis has been upgraded after more than 10 years of Research and Development investment to support heavier vehicle operating weights, thereby increasing payload capacity at the same time as providing full crew protection with modular and scaleable kitted armor. Additionally, the upgraded cooling system provides higher cooling capacity to ensure the HMMWV will meet or exceed all operational requirements at a heavier operating weight and in significantly higher temperature environments.  Specific improvements include: 400-amp alternator; Enhanced air lift brackets; Front mounted AC condenser; heavy duty shocks; high capacity disc brakes; improved cooling with gear fan drive; reduced effort steering; increased load rated wheels; robust 3-piece frame rails; dedicated parking brake; rear differential improved cooling capacity. HMMWV Parts, Service and Training – AM General is uniquely capable of providing parts, service and training on all HMMWV configurations built over the last 30 years and currently in service. AM General builds most of the critical spare parts including engine, transmission and suspension components and AM General certified parts are available through our global parts provider Brighton Cromwell.  Representatives will be on hand to discuss the company's award-winning, worldwide supply chain management and field service support, dealer and technician training, advanced driver training and warranty support. Media wishing to schedule interviews should call or e-mail Jeff Adams, 703-347-2276; e-mail: jeff.adams@amgeneral.com  with the following information on their representative(s) who will attend the event: About AM General AM General designs, engineers, manufactures, supplies and supports specialized vehicles for military and commercial customers worldwide. Through its military business, the company is widely recognized as the world leader in design, engineer, manufacture and support of Light Tactical Vehicles, having produced and sustained more than 300,000 vehicles in over 60 countries. Its growing commercial business includes its wholly owned subsidiary, Mobility Ventures, designer and manufacturer of the acclaimed MV-1, the only American made vehicle specifically engineered from the ground up in support of wheelchair users and people with disabilities. AM General is also proud to have been selected by Mercedes-Benz to be its only contract manufacturer in the United States, producing the R-Class vehicle in Mishawaka, Ind.  Additionally, the company was selected by the U.S. Postal Service to develop and test advanced automotive technologies for use in the Next Generation Delivery Vehicle program. AM General has more than five decades of experience meeting the changing needs of the defense and automotive industries, supported by its employees at major facilities in Indiana, Michigan, and Ohio, and a strong supplier base that stretches across 43 states. Please see more information about AM General at www.amgeneral.com.


BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (NYSE: MPW) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.24 per share of common stock to be paid on April 13, 2017, to stockholders of record on March 16, 2017. Today’s declaration marks the third consecutive year of a cash dividend increase resulting in a 14 percent increase compared to 2014 dividends. “We are pleased to continue to increase our cash dividends to shareholders commensurate with growing Funds from Operations,” said Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer. “With this increase, we continue to maintain our strong payout ratio of between 75% and 80% of adjusted funds from operations.” Medical Properties Trust also announced that its annual meeting of shareholders will be held at the Summit Club in Birmingham, Alabama at 10:30 a.m. Central Time on May 25, 2017. Shareholders of record as of March 20, 2017, will be invited to attend. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. For more information, please visit the Company’s website at www.medicalpropertiestrust.com. The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as "expects," "believes," "anticipates," "intends," "will," "should" and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the payment of future dividends, if any; increases to future dividend payments; expected dividend payout ratio, and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the "Risk factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2015, and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.


Sendo o quarto[2] mercado de telefonia móvel que mais cresce no mundo, Mianmar experimentou um tremendo crescimento da penetração de celulares nos últimos anos, indo de 10% em 2012 para 63% em 2016[3], respondendo hoje por 6% dos assinantes de telefonia móvel no mundo. Tendo lançado sua rede 4G em 2016[4], a MPT está comprometida em desenvolver ainda mais o uso de 4G. Isso ocorre, por exemplo, quando coleta e analisa em tempo real os dados dos usuários e aparelhos telefônicos através de recursos estatísticos avançados com o uso do Device Management. Outras soluções avançadas, como o AOTA, dão à MPT uma vantagem competitiva na entrega remota de serviços, que por sua vez reduz os transtornos e melhora a experiência do cliente. "Essas facilidades representam um enorme passo adiante para a MPT. Agora conseguimos entender nossos assinantes, desenvolver serviços personalizados para atender as necessidades dos clientes e impulsionar as oportunidades de negócios", disse Koichi Kawase, Diretor Comercial de Operações Conjuntas MPT-KSGM. "O objetivo principal da MPT é oferecer o mais conceituado serviço para seus clientes. Portanto, essa colaboração, construída com base em conhecimento global e tecnologias comprovadas no setor, irá nos permitir alcançar uma conveniência ainda maior e uma experiência de telefonia móvel privilegiada para os clientes em Mianmar." O conteúdo deste comunicado de imprensa é uma tradução e não deverá, em qualquer circunstância, ser considerado oficial. A versão original do comunicado de imprensa em inglês é a única versão confiável e deverá prevalecer no caso de haver discrepâncias com a tradução.


BALTIMORE, MD, February 22, 2017 /24-7PressRelease/ -- A Baltimore-based professional organizing company, Simplify Organizing, LLC ("Simplify"), designates February as "Declutter for a Cause Month." The organizing company has even sent in an application to register it as a national holiday. Simplify's mission is to help individuals and families shed household clutter and create easy organizational systems, but this month, the company plans to extend its reach beyond homeowners' kitchens and garages to assist a local non-profit organization, 901 Arts. The community-based youth arts center provides art and music programs to the children and teens of the Better Waverly neighborhood in Baltimore City. Each year, more than one hundred youths actively participate in art and video production classes, music lessons, homework club, and summer camps offered by 901 Arts. This past fall, Simplify's owner, Amy Rehkemper, got a call from one of her clients who explained how she tried to donate some craft supplies to 901 Arts, but they had barely any available storage space to accept the useful items. Upon hearing this news, Rehkemper committed to helping the non-profit declutter and organize its arts center and she and her staff offered to work pro bono. "They are doing so much 'right,' but it's time they turn-over their storage areas to the left-brained!" said Rehkemper. 901 Arts Director, Sarah Tooley, took Rehkemper on a tour of the Center located at 901 Montpeiler Street and shared her frustrations with the disorganization and lack of storage space. "The basement storage room is so stuffed that it's hard for our volunteer teachers to make use of the donations we receive," explained Tooley. "We host many events for the community, like our annual fundraiser 901 Day and even a Haunted House every October, but volunteers have difficulty accessing our decorations and supplies which adds undue stress and wastes time." After walking through their basement piled high with colorful paint, craft supplies, and costumes spilling out of every corner, Rehkemper took the matter to her team of professional organizers and together they committed to not only help this year, but to do this type of community outreach at least once every year. "We want to help too," said Jill Prevatt, one of Simplify's expert organizers, "it's a pleasure to offer our services to such a terrific charity." Rehkemper and her staff of organizers hope that creating a national holiday "Declutter for a Cause Month" will encourage others who are skilled at organizing to offer free assistance to non-profits in Baltimore, and across the nation. "Non-profits are generally over-worked and under-staffed, so they rarely have time to devote to the actual organization of their organization," said Rehkemper. The Simplify Team has a three-part plan: first, they will partner with local haulers to clear the clutter; second, they will sort the remaining items into categories and zones; and third, they will devise systems, introduce routines, and train the 901 staff on how to maintain the newly organized set-up. 901 Arts is an integral part of the community's ongoing efforts to build a safer, stronger and more vibrant neighborhood. Director Tooley and her team of artists and musicians anticipate that this organizational make-over will save them time, relieve daily frustrations, and improve their overall productivity so that more energy can be placed on the kids they serve, not the clutter. "This building provides a foundation for our art and music programs," said Director Tooley. "It's a safe place for kids to be creative and express themselves, but for it to run smoothly, we need better organization and systems, so I'm thrilled by Simplify's offer to help. For the sake of all community groups devoted to social change, I hope 'Declutter for a Cause Month' becomes hugely popular!" Supporters of 901 Arts are welcome to donate funds online at http://bit.ly/ICP5rb to contribute towards new containers and art supply storage pieces for what is predicted to be an organizational work of art! About Simplify Organizing, LLC Simplify Organizing, LLC has been clearing clutter and making homes happier since 1999. The company offers hands-on decluttering and organizing services for homeowners in the Baltimore-Washington vicinity. The company's focus is on helping families and specializes in digital photo organizing, household file system set-ups, custom closet design, and will even organize your next move! Owner, Amy Rehkemper, CPO was one of the first Certified Professional Organizers in the U.S. and has been featured on HGTV, Fox 45, WJZ, ABC 2, MPT & WYPR. The company is based in Towson, Maryland, and has been twice-voted Baltimore Magazine's Best of Baltimore. To learn more, please visit http://www.simplifyorganizing.com. About 901 Arts 901 Arts is a community-based youth arts center dedicated to providing art and music programs to the children and teens of the Better Waverly neighborhood. They offer a supportive and community-focused space for developing one's creative and leadership abilities. Founded in 2006 by parents and adults in the neighborhood, 901 Arts is a project of the Better Waverly Community Organization.

Loading MPT collaborators
Loading MPT collaborators